GlassScriptPhysician profile
Andrew J Applewhite
NPI 1063472991
$46,091.22
in general payments reported to CMS, 2019-2025
28 companies · $2,894 in 2025
The $2,894 reported for 2025 was more than what 92% of Undersea and Hyperbaric Medicine (Preventive Medicine) providers received nationally (typical 2025 total: $210).
See the full distribution for Undersea and Hyperbaric Medicine (Preventive Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,367 · 2021: $3,836 · 2022: $9,619 · 2023: $1,778 · 2024: $8,508 · 2025: $2,894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,187 · Food and Beverage: $3,192 · Travel and Lodging: $751 · Education: $48.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,186.98 |
| Food and Beverage | $3,192.46 |
| Travel and Lodging | $751.10 |
| Education | $48.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $19,056.81 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $16,133.40 | 2019-2023 | Promogran Prisma, Abthera Advance, 3m Cavilon |
| Solventum Corporation | $4,458.59 | 2024-2025 | Activ.A.C., Promogran Prisma, V.A.C. Veraflo |
| Lifenet Health | $1,481.45 | 2023-2025 | Theragenesis Wound Matrix |
| Smith+Nephew, INC. | $1,068.12 | 2019-2025 | Grafix Pl, Oasis, Stravix |
| Misonix INC | $740.50 | 2019-2021 | |
| Sanara Medtech INC. | $577.02 | 2021-2023 | |
| Urgo Medical North America, LLC | $404.76 | 2023-2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Organogenesis INC. | $253.97 | 2019-2022 | |
| Inari Medical, INC. | $229.08 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kerecis Limited | $219.32 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Progenacare Global, LLC | $216.77 | 2023 | |
| Aroa Biosurgery Incorporated | $186.33 | 2019-2025 | |
| Medtronic, INC. | $156.46 | 2023-2025 | Hawkone |
| Stryker Corporation | $150.30 | 2024 | Viaflow, Allowrap, Bioskin |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $147.03 | 2022 | |
| Next Science LLC | $113.23 | 2024 | Surgx, Blastx, Xperience |
| Molnlycke Health Care US, LLC | $109.65 | 2019 | |
| Convatec INC. | $85.21 | 2019-2023 | |
| Owens & Minor | $74.30 | 2024 | |
| Coloplast Corp | $66.06 | 2020-2023 | Triad |
| Ets Wound Care LLC | $32.06 | 2023 | |
| Access Pro Medical, LLC | $27.66 | 2025 | Matriderm |
| Tactile Systems Technology INC | $26.59 | 2019-2020 | |
| Hill-Rom Company, INC | $23.24 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $21.64 | 2023 | |
| Hydrofera LLC | $18.31 | 2022 | |
| Osiris Therapeutics INC. | $13.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Applewhite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.